This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Joan Stephenson, PhD

JAMA. 1999;281:309-310.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

WASHINGTON—AIDS experts are predicting that new tests designed to identify drug-resistant strains of HIV will soon emerge as important tools to help physicians make decisions regarding therapeutic regimens for patients with the infection.

Experts predict that new tests that demonstrate whether a strain of HIV (in orange) is resistant to anti-HIV drugs will become important tools for guiding therapy. (Photo credit: CNRI/Science Photo Library)

That was the prevailing take-home message from AIDS scientists who gathered here last month for an international workshop, "Clinical Indications of HIV Drug Resistance Monitoring," organized by International Medical Press and The Johns Hopkins School of Medicine.

"It's increasingly apparent that these tests will be part of the monitoring and management of HIV patients in the very near future," said Douglas Richman, MD, of the University of California, San Diego, and the San Diego VA Medical Center. In a recent consensus statement, . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?